CoLucid Pharmaceuticals

Indianapolis, IN

CoLucid Pharmaceuticals is a clinical stage biopharmaceutical company developing therapeutics to treat neurological dysfunctions. CoLucid’s lead program is based on a potent and selective 5-HT1F receptor agonist that has the potential to be useful in the acute treatment and/or prevention or prophylaxis of migraine headaches. The company also possesses a robust chemistry platform that will produce unique bifunctional neuromodulators to treat indications such as Alzheimer's disease.